▶ 調査レポート

潰瘍性大腸炎治療薬のアメリカ市場2017

• 英文タイトル:United States Ulcerative Colitis Drugs Market Report 2017

QYResearchが調査・発行した産業分析レポートです。潰瘍性大腸炎治療薬のアメリカ市場2017 / United States Ulcerative Colitis Drugs Market Report 2017 / A042121617資料のイメージです。• レポートコード:A042121617
• 出版社/出版日:QYResearch / 2017年3月2日
• レポート形態:英文、PDF、113ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥402,800 (USD3,800)▷ お問い合わせ
  Enterprise¥805,600 (USD7,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、潰瘍性大腸炎治療薬のアメリカ市場について調査・分析し、潰瘍性大腸炎治療薬のアメリカ市場概観、潰瘍性大腸炎治療薬の種類別市場分析、用途別市場分析、潰瘍性大腸炎治療薬のアメリカ市場規模予測、関連企業分析、関連企業情報、価格情報、販売動向、アメリカ市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・潰瘍性大腸炎治療薬のアメリカ市場概観
・潰瘍性大腸炎治療薬の種類別市場規模
・潰瘍性大腸炎治療薬の用途別市場規模
・潰瘍性大腸炎治療薬のアメリカ市場規模
・潰瘍性大腸炎治療薬のアメリカ市場予測
・潰瘍性大腸炎治療薬の製造メーカー分析
・潰瘍性大腸炎治療薬のメーカー別生産量
・潰瘍性大腸炎治療薬のメーカー別市場シェア
・潰瘍性大腸炎治療薬の価格動向・価格分析
・潰瘍性大腸炎治療薬の販売(売上高)動向
・潰瘍性大腸炎治療薬の貿易(輸出・輸入)動向
・潰瘍性大腸炎治療薬の産業チェーン分析
・潰瘍性大腸炎治療薬のマーケティング戦略分析
・潰瘍性大腸炎治療薬の販売業者(代理店)リスト
・潰瘍性大腸炎治療薬の市場環境分析
...

Notes:Sales, means the sales volume of Ulcerative Colitis Drugs
Revenue, means the sales value of Ulcerative Colitis Drugs

This report studies sales (consumption) of Ulcerative Colitis Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
AbbVie
Janssen Pharmaceutical
Merck
Takeda Pharmaceuticals
AstraZeneca
GlaxoSmithKline
Pfizer
Amgen
Abbott
Procter & Gamble
Cosmo Pharmaceuticals
Eisai
Ferring Pharmaceuticals
Nestle
Zeria
Kissei Pharmaceutical
Kaken Pharmaceutical
Hutchison MediPharma

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Biologics
Small Molecules
Split by applications, this report focuses on sales, market share and growth rate of Ulcerative Colitis Drugs in each application, can be divided into
Application 1
Application 2

レポート目次

Table of Contents

United States Ulcerative Colitis Drugs Market Report 2017
1 Ulcerative Colitis Drugs Overview
1.1 Product Overview and Scope of Ulcerative Colitis Drugs
1.2 Classification of Ulcerative Colitis Drugs
1.2.1 Biologics
1.2.2 Small Molecules
1.3 Application of Ulcerative Colitis Drugs
1.3.1 Application 1
1.3.2 Application 2
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Ulcerative Colitis Drugs (2012-2022)
1.4.1 United States Ulcerative Colitis Drugs Sales and Growth Rate (2012-2022)
1.4.2 United States Ulcerative Colitis Drugs Revenue and Growth Rate (2012-2022)

2 United States Ulcerative Colitis Drugs Competition by Manufacturers
2.1 United States Ulcerative Colitis Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Ulcerative Colitis Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Ulcerative Colitis Drugs Average Price by Manufactures (2015 and 2016)
2.4 Ulcerative Colitis Drugs Market Competitive Situation and Trends
2.4.1 Ulcerative Colitis Drugs Market Concentration Rate
2.4.2 Ulcerative Colitis Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Ulcerative Colitis Drugs Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Ulcerative Colitis Drugs Sales and Market Share by States (2012-2017)
3.2 United States Ulcerative Colitis Drugs Revenue and Market Share by States (2012-2017)
3.3 United States Ulcerative Colitis Drugs Price by States (2012-2017)

4 United States Ulcerative Colitis Drugs Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Ulcerative Colitis Drugs Sales and Market Share by Type (2012-2017)
4.2 United States Ulcerative Colitis Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Ulcerative Colitis Drugs Price by Type (2012-2017)
4.4 United States Ulcerative Colitis Drugs Sales Growth Rate by Type (2012-2017)

5 United States Ulcerative Colitis Drugs Sales (Volume) by Application (2012-2017)
5.1 United States Ulcerative Colitis Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Ulcerative Colitis Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Ulcerative Colitis Drugs Manufacturers Profiles/Analysis
6.1 AbbVie
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Ulcerative Colitis Drugs Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 AbbVie Ulcerative Colitis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Janssen Pharmaceutical
6.2.2 Ulcerative Colitis Drugs Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Janssen Pharmaceutical Ulcerative Colitis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Merck
6.3.2 Ulcerative Colitis Drugs Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Merck Ulcerative Colitis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Takeda Pharmaceuticals
6.4.2 Ulcerative Colitis Drugs Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Takeda Pharmaceuticals Ulcerative Colitis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 AstraZeneca
6.5.2 Ulcerative Colitis Drugs Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 AstraZeneca Ulcerative Colitis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 GlaxoSmithKline
6.6.2 Ulcerative Colitis Drugs Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 GlaxoSmithKline Ulcerative Colitis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Pfizer
6.7.2 Ulcerative Colitis Drugs Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Pfizer Ulcerative Colitis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Amgen
6.8.2 Ulcerative Colitis Drugs Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Amgen Ulcerative Colitis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Abbott
6.9.2 Ulcerative Colitis Drugs Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Abbott Ulcerative Colitis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Procter & Gamble
6.10.2 Ulcerative Colitis Drugs Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Procter & Gamble Ulcerative Colitis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Cosmo Pharmaceuticals
6.12 Eisai
6.13 Ferring Pharmaceuticals
6.14 Nestle
6.15 Zeria
6.16 Kissei Pharmaceutical
6.17 Kaken Pharmaceutical
6.18 Hutchison MediPharma

7 Ulcerative Colitis Drugs Manufacturing Cost Analysis
7.1 Ulcerative Colitis Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Ulcerative Colitis Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Ulcerative Colitis Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Ulcerative Colitis Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Ulcerative Colitis Drugs Market Forecast (2017-2022)
11.1 United States Ulcerative Colitis Drugs Sales, Revenue Forecast (2017-2022)
11.2 United States Ulcerative Colitis Drugs Sales Forecast by Type (2017-2022)
11.3 United States Ulcerative Colitis Drugs Sales Forecast by Application (2017-2022)
11.4 Ulcerative Colitis Drugs Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Ulcerative Colitis Drugs
Table Classification of Ulcerative Colitis Drugs
Figure United States Sales Market Share of Ulcerative Colitis Drugs by Type in 2015
Figure Biologics Picture
Figure Small Molecules Picture
Table Application of Ulcerative Colitis Drugs
Figure United States Sales Market Share of Ulcerative Colitis Drugs by Application in 2015
Figure United States Ulcerative Colitis Drugs Sales and Growth Rate (2012-2022)
Figure United States Ulcerative Colitis Drugs Revenue and Growth Rate (2012-2022)
Table United States Ulcerative Colitis Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Ulcerative Colitis Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Ulcerative Colitis Drugs Sales Share by Manufacturers
Figure 2016 Ulcerative Colitis Drugs Sales Share by Manufacturers
Table United States Ulcerative Colitis Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Ulcerative Colitis Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Ulcerative Colitis Drugs Revenue Share by Manufacturers
Table 2016 United States Ulcerative Colitis Drugs Revenue Share by Manufacturers
Table United States Market Ulcerative Colitis Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Ulcerative Colitis Drugs Average Price of Key Manufacturers in 2015
Figure Ulcerative Colitis Drugs Market Share of Top 3 Manufacturers
Figure Ulcerative Colitis Drugs Market Share of Top 5 Manufacturers
Table United States Ulcerative Colitis Drugs Sales by States (2012-2017)
Table United States Ulcerative Colitis Drugs Sales Share by States (2012-2017)
Figure United States Ulcerative Colitis Drugs Sales Market Share by States in 2015
Table United States Ulcerative Colitis Drugs Revenue and Market Share by States (2012-2017)
Table United States Ulcerative Colitis Drugs Revenue Share by States (2012-2017)
Figure Revenue Market Share of Ulcerative Colitis Drugs by States (2012-2017)
Table United States Ulcerative Colitis Drugs Price by States (2012-2017)
Table United States Ulcerative Colitis Drugs Sales by Type (2012-2017)
Table United States Ulcerative Colitis Drugs Sales Share by Type (2012-2017)
Figure United States Ulcerative Colitis Drugs Sales Market Share by Type in 2015
Table United States Ulcerative Colitis Drugs Revenue and Market Share by Type (2012-2017)
Table United States Ulcerative Colitis Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Ulcerative Colitis Drugs by Type (2012-2017)
Table United States Ulcerative Colitis Drugs Price by Type (2012-2017)
Figure United States Ulcerative Colitis Drugs Sales Growth Rate by Type (2012-2017)
Table United States Ulcerative Colitis Drugs Sales by Application (2012-2017)
Table United States Ulcerative Colitis Drugs Sales Market Share by Application (2012-2017)
Figure United States Ulcerative Colitis Drugs Sales Market Share by Application in 2015
Table United States Ulcerative Colitis Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Ulcerative Colitis Drugs Sales Growth Rate by Application (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Ulcerative Colitis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AbbVie Ulcerative Colitis Drugs Sales Market Share (2012-2017)
Table Janssen Pharmaceutical Basic Information List
Table Janssen Pharmaceutical Ulcerative Colitis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Janssen Pharmaceutical Ulcerative Colitis Drugs Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Ulcerative Colitis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Ulcerative Colitis Drugs Sales Market Share (2012-2017)
Table Takeda Pharmaceuticals Basic Information List
Table Takeda Pharmaceuticals Ulcerative Colitis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Takeda Pharmaceuticals Ulcerative Colitis Drugs Sales Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Ulcerative Colitis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Ulcerative Colitis Drugs Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Ulcerative Colitis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Ulcerative Colitis Drugs Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Ulcerative Colitis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Ulcerative Colitis Drugs Sales Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Ulcerative Colitis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Ulcerative Colitis Drugs Sales Market Share (2012-2017)
Table Abbott Basic Information List
Table Abbott Ulcerative Colitis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Ulcerative Colitis Drugs Sales Market Share (2012-2017)
Table Procter & Gamble Basic Information List
Table Procter & Gamble Ulcerative Colitis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Procter & Gamble Ulcerative Colitis Drugs Sales Market Share (2012-2017)
Table Cosmo Pharmaceuticals Basic Information List
Table Eisai Basic Information List
Table Ferring Pharmaceuticals Basic Information List
Table Nestle Basic Information List
Table Zeria Basic Information List
Table Kissei Pharmaceutical Basic Information List
Table Kaken Pharmaceutical Basic Information List
Table Hutchison MediPharma Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ulcerative Colitis Drugs
Figure Manufacturing Process Analysis of Ulcerative Colitis Drugs
Figure Ulcerative Colitis Drugs Industrial Chain Analysis
Table Raw Materials Sources of Ulcerative Colitis Drugs Major Manufacturers in 2015
Table Major Buyers of Ulcerative Colitis Drugs
Table Distributors/Traders List
Figure United States Ulcerative Colitis Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States Ulcerative Colitis Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States Ulcerative Colitis Drugs Production Forecast by Type (2017-2022)
Table United States Ulcerative Colitis Drugs Consumption Forecast by Application (2017-2022)
Table United States Ulcerative Colitis Drugs Sales Forecast by States (2017-2022)
Table United States Ulcerative Colitis Drugs Sales Share Forecast by States (2017-2022)